-
The need for even further progress with clinical trial data sharing efforts: patients are waiting
Sandra Morris, Karla G Childers, Jesse A Berlin, Joanne Waldstreicher
Editorial: Clinical Investigation
-
The need for even further progress with clinical trial data sharing efforts: patients are waiting
Sandra Morris, Karla G Childers, Jesse A Berlin, Joanne Waldstreicher
Editorial: Clinical Investigation
-
The need for even further progress with clinical trial data sharing efforts: patients are waiting
Sandra Morris, Karla G Childers, Jesse A Berlin, Joanne Waldstreicher
Editorial: Clinical Investigation
-
The need for even further progress with clinical trial data sharing efforts: patients are waiting
Sandra Morris, Karla G Childers, Jesse A Berlin, Joanne Waldstreicher
Editorial: Clinical Investigation
-
The need for even further progress with clinical trial data sharing efforts: patients are waiting
Sandra Morris, Karla G Childers, Jesse A Berlin, Joanne Waldstreicher
Editorial: Clinical Investigation
-
The need for even further progress with clinical trial data sharing efforts: patients are waiting
Sandra Morris, Karla G Childers, Jesse A Berlin, Joanne Waldstreicher
Editorial: Clinical Investigation
-
The need for even further progress with clinical trial data sharing efforts: patients are waiting
Sandra Morris, Karla G Childers, Jesse A Berlin, Joanne Waldstreicher
Editorial: Clinical Investigation
-
The need for even further progress with clinical trial data sharing efforts: patients are waiting
Sandra Morris, Karla G Childers, Jesse A Berlin, Joanne Waldstreicher
Editorial: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Can mouse models of cancer reliably improve clinical trial outcome?
Grit S Herter-Sprie & Kwok-Kin Wong
Clinical Trail Prospective: Clinical Investigation
-
Can mouse models of cancer reliably improve clinical trial outcome?
Grit S Herter-Sprie & Kwok-Kin Wong
Clinical Trail Prospective: Clinical Investigation
-
Can mouse models of cancer reliably improve clinical trial outcome?
Grit S Herter-Sprie & Kwok-Kin Wong
Clinical Trail Prospective: Clinical Investigation
-
Can mouse models of cancer reliably improve clinical trial outcome?
Grit S Herter-Sprie & Kwok-Kin Wong
Clinical Trail Prospective: Clinical Investigation
-
Can mouse models of cancer reliably improve clinical trial outcome?
Grit S Herter-Sprie & Kwok-Kin Wong
Clinical Trail Prospective: Clinical Investigation
-
Can mouse models of cancer reliably improve clinical trial outcome?
Grit S Herter-Sprie & Kwok-Kin Wong
Clinical Trail Prospective: Clinical Investigation
-
Can mouse models of cancer reliably improve clinical trial outcome?
Grit S Herter-Sprie & Kwok-Kin Wong
Clinical Trail Prospective: Clinical Investigation
-
Can mouse models of cancer reliably improve clinical trial outcome?
Grit S Herter-Sprie & Kwok-Kin Wong
Clinical Trail Prospective: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation